0
0
2/12/23 at 12:00pm
Organization
Targetedonc.com
Author
Jonah Feldman
40 words
0
Comments
In an interview with Targeted Oncology™, Nathan Bahary, MD, PhD, discussed adapting to new therapy options and what the future holds for improving care for patients with cholangiocarcinoma.
You are the first to view
https://www.targetedonc.com/view/cholangiocarcinoma-awareness-day-advances-in-frontline-and-later-btc-therapies
Create an account
or login to join the discussion